<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="Publisher" Owner="NLM">        <PMID Version="1">30187259</PMID>        <DateRevised>            <Year>2018</Year>            <Month>09</Month>            <Day>06</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1863-6713</ISSN>                <JournalIssue CitedMedium="Internet">                    <PubDate>                        <Year>2018</Year>                        <Month>Sep</Month>                        <Day>05</Day>                    </PubDate>                </JournalIssue>                <Title>General thoracic and cardiovascular surgery</Title>                <ISOAbbreviation>Gen Thorac Cardiovasc Surg</ISOAbbreviation>            </Journal>            <ArticleTitle>Clinicopathologic characteristics of non-small cell lung cancer in patients with smoking-related chronic obstructive pulmonary disease.</ArticleTitle>            <ELocationID EIdType="doi" ValidYN="Y">10.1007/s11748-018-1007-x</ELocationID>            <Abstract>                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The purpose of this study was to clarify the clinicopathologic characteristics of non-small cell lung cancer (NSCLC) patients with smoking-related chronic obstructive pulmonary disease (COPD) and to evaluate the biological behavior of this disease. We investigated the association between smoking-related COPD, the recurrence-free proportion (RFP) and the clinicopathological features of clinical stage I NSCLC patients.</AbstractText>                <AbstractText Label="METHODS" NlmCategory="METHODS">Between 2005 and 2014, 218 consecutive patients with clinical stage I NSCLC underwent complete resection with lobectomy or greater and systematic lymph node dissection. Differences in categorical outcomes were evaluated by the χ<sup>2</sup> test. RFPs were estimated using the Kaplan-Meier method, and differences were evaluated using the log-rank test.</AbstractText>                <AbstractText Label="RESULTS" NlmCategory="RESULTS">The 5-year RFP of clinical stage I NSCLC patients with smoking-related COPD was 55%, which was significantly lower than in those without smoking-related COPD (85%; p &lt; 0.001). Postoperative pathological factors, including moderate or poor histological differentiation, intratumoral vascular invasion and lymph node metastasis, were detected more often in patients with smoking-related COPD. In adenocarcinoma patients, the 5-year RFP of patients with smoking-related COPD was 47%, which was significantly lower than in those without smoking-related COPD (87%; p &lt; 0.001). The presence of a solid component was more frequently found in patients with smoking-related COPD (p = 0.007).</AbstractText>                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Clinical stage I NSCLC patients with smoking-related COPD have histologically more invasive tumors than those without smoking-related COPD.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Maeda</LastName>                    <ForeName>Ryo</ForeName>                    <Initials>R</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0001-7223-8817</Identifier>                    <AffiliationInfo>                        <Affiliation>Department of Thoracic and Breast Surgery, Faculty of Medicine, University of Miyazaki, Kihara 5200, Kiyotake, Miyazaki, 889-1692, Japan. ryo_maeda@med.miyazaki-u.ac.jp.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Tomita</LastName>                    <ForeName>Masaki</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Thoracic and Breast Surgery, Faculty of Medicine, University of Miyazaki, Kihara 5200, Kiyotake, Miyazaki, 889-1692, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Usuda</LastName>                    <ForeName>Katsuo</ForeName>                    <Initials>K</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Thoracic Surgery, Kanazawa Medical University, Kanazawa, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Uramoto</LastName>                    <ForeName>Hidetaka</ForeName>                    <Initials>H</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Thoracic Surgery, Kanazawa Medical University, Kanazawa, Japan.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>09</Month>                <Day>05</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>Japan</Country>            <MedlineTA>Gen Thorac Cardiovasc Surg</MedlineTA>            <NlmUniqueID>101303952</NlmUniqueID>            <ISSNLinking>1863-6705</ISSNLinking>        </MedlineJournalInfo>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Adenocarcinoma</Keyword>            <Keyword MajorTopicYN="N">Chronic obstructive pulmonary disease</Keyword>            <Keyword MajorTopicYN="N">Clinical stage I</Keyword>            <Keyword MajorTopicYN="N">Non-small cell lung cancer</Keyword>            <Keyword MajorTopicYN="N">Thoracic surgery</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>04</Month>                <Day>09</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>09</Month>                <Day>02</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>9</Month>                <Day>7</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>9</Month>                <Day>7</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>9</Month>                <Day>7</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>aheadofprint</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30187259</ArticleId>            <ArticleId IdType="doi">10.1007/s11748-018-1007-x</ArticleId>            <ArticleId IdType="pii">10.1007/s11748-018-1007-x</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>